Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants

NCT05358691 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT05358691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05358691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Phase 1
Overall status
Withdrawn
Start date
November 1, 2024
Completion date
June 1, 2028
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer stage iii